Finch Therapeutics Group Financials

Finch Therapeutics Stock Summary

Finch Therapeutics competes with Werewolf Therapeutics, Edgewise Therapeutics, Celcuity LLC, C4 Therapeutics, and Ikena Oncology. Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts. Finch Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 189 people.

Finch Therapeutics Key Financial Ratios

Finch Therapeutics' financial ratios allow both analysts and investors to convert raw data from Finch Therapeutics' financial statements into concise, actionable information that can be used to evaluate the performance of Finch Therapeutics over time and compare it to other companies across industries.

Finch Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Finch Therapeutics's current stock value. Our valuation model uses many indicators to compare Finch Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Finch Therapeutics competition to find correlations between indicators driving Finch Therapeutics's intrinsic value. More Info.Finch Therapeutics Group is rated below average in return on equity category among its peers. It is rated # 4 in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Finch Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Finch Therapeutics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Finch Therapeutics Market Pulse

Along with financial statement analysis, the daily predictive indicators of Finch Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Finch Therapeutics Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Finch Therapeutics Group based on widely used predictive technical indicators. In general, we focus on analyzing Finch Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Finch Therapeutics's daily price indicators and compare them against related drivers.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

If you are still planning to invest in Finch Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Finch Therapeutics' history and understand the potential risks before investing.